Barrington Research Cuts Merit Medical Systems (NASDAQ:MMSI) Price Target to $107.00

Merit Medical Systems (NASDAQ:MMSI) had its price target trimmed by Barrington Research from $109.00 to $107.00 in a report issued on Monday morning,Benzinga reports. They currently have an outperform rating on the medical instruments supplier’s stock.

A number of other research analysts have also commented on MMSI. Weiss Ratings restated a “hold (c)” rating on shares of Merit Medical Systems in a research note on Friday, March 27th. Wall Street Zen lowered Merit Medical Systems from a “strong-buy” rating to a “buy” rating in a research note on Sunday, April 5th. Needham & Company LLC restated a “buy” rating and issued a $101.00 target price on shares of Merit Medical Systems in a research note on Wednesday, April 1st. Wells Fargo & Company lowered Merit Medical Systems from an “overweight” rating to an “equal weight” rating and cut their target price for the company from $95.00 to $78.00 in a research note on Thursday, February 26th. Finally, Piper Sandler cut their target price on Merit Medical Systems from $106.00 to $96.00 and set an “overweight” rating for the company in a research note on Friday, April 17th. Eight analysts have rated the stock with a Buy rating and three have issued a Hold rating to the stock. According to data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus price target of $99.56.

Merit Medical Systems Stock Up 2.7%

Shares of MMSI stock opened at $69.72 on Monday. Merit Medical Systems has a 12 month low of $66.34 and a 12 month high of $100.19. The firm has a market cap of $4.16 billion, a PE ratio of 32.89, a price-to-earnings-growth ratio of 1.91 and a beta of 0.64. The stock has a 50 day moving average of $72.36 and a 200-day moving average of $80.39. The company has a quick ratio of 2.95, a current ratio of 4.34 and a debt-to-equity ratio of 0.46.

Merit Medical Systems (NASDAQ:MMSI) last issued its quarterly earnings results on Tuesday, February 24th. The medical instruments supplier reported $1.04 EPS for the quarter, topping analysts’ consensus estimates of $0.96 by $0.08. The company had revenue of $393.94 million during the quarter, compared to analyst estimates of $390.77 million. Merit Medical Systems had a return on equity of 13.82% and a net margin of 8.48%.The company’s quarterly revenue was up 10.9% compared to the same quarter last year. During the same period in the previous year, the company earned $0.93 earnings per share. Merit Medical Systems has set its FY 2026 guidance at 4.010-4.150 EPS. On average, equities analysts predict that Merit Medical Systems will post 3.62 EPS for the current year.

Institutional Trading of Merit Medical Systems

Large investors have recently bought and sold shares of the stock. Los Angeles Capital Management LLC bought a new stake in Merit Medical Systems in the fourth quarter valued at $25,000. Maseco LLP bought a new stake in Merit Medical Systems in the fourth quarter valued at $26,000. Torren Management LLC bought a new stake in Merit Medical Systems in the fourth quarter valued at $38,000. Salomon & Ludwin LLC bought a new stake in Merit Medical Systems in the third quarter valued at $37,000. Finally, Covestor Ltd grew its position in Merit Medical Systems by 252.6% in the fourth quarter. Covestor Ltd now owns 469 shares of the medical instruments supplier’s stock valued at $41,000 after acquiring an additional 336 shares during the period. 99.66% of the stock is currently owned by institutional investors.

About Merit Medical Systems

Merit Medical Systems, Inc is a global manufacturer and marketer of a broad range of medical devices used in diagnostic and interventional procedures. The company’s product portfolio encompasses vascular access, drainage, embolotherapy, and interventional oncology devices, as well as radiofrequency ablation systems and hemostasis solutions. These products serve physicians and hospitals in critical care settings and support minimally invasive treatment options across multiple specialties, including cardiology, radiology, oncology, neurology and endoscopy.

Founded in 1987 by Fred Lampropoulos, Merit Medical Systems has grown through both organic development and targeted acquisitions to expand its technology offerings and geographic reach.